Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1216.31x is 346% below its 2-year average of -272.73x, near the low end of its 2-year range (-1216.31x–-23.54x).
As of the fiscal period ended Friday, June 30, 2023. 145.25% below its 12-month average of -495.94x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2023 (2023-06-30): -1216.31x.
INTEREST COVERAGE RATIO
-1216.31x
INTEREST COVERAGE RATIO AVG TTM
-495.94x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-145.25%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 442 covered companies
CURRENT VS SECTOR MEDIAN
-21484.90%
vs the sector median at left
Lucyd, Inc
Market Cap
$5.85M
Interest Coverage Ratio
-1216.31x
TTM Avg
-495.94x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.77M
Interest Coverage Ratio
N/A
TTM Avg
2443.20x
3Y Avg
2443.20x
5Y Avg
2443.20x
Market Cap
$5.66M
Interest Coverage Ratio
-310.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.94M
Interest Coverage Ratio
-1153.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.01M
Interest Coverage Ratio
-438.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.27M
Interest Coverage Ratio
N/A
TTM Avg
1010.31x
3Y Avg
1010.31x
5Y Avg
509.98x
Market Cap
$5.29M
Interest Coverage Ratio
1324.50x
TTM Avg
1324.50x
3Y Avg
1324.50x
5Y Avg
1324.50x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lucyd, Inc (LUCY) | $5.85M | -1216.31x | -495.94x | N/A | N/A |
| enVVeno Medical Corporation (NVNO)vs › | $5.77M | N/A | 2443.20x | 2443.20x | 2443.20x |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.66M | -310.21x | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.94M | -1153.85x | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.01M | -438.08x | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | N/A | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.27M | N/A | 1010.31x | 1010.31x | 509.98x |
| Femasys Inc. (FEMY)vs › | $6.31M | -9.30x | N/A | N/A | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | 1324.50x | 1324.50x | 1324.50x | 1324.50x |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.47M | -545.69x | N/A | N/A | N/A |
Interest Coverage
-1216.3x
Debt/Equity
0.01
Current Ratio
12.06
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-06-30 | -1216.31x |
| 2023-03-31 | -736.95x |
| 2022-12-31 | -465.15x |
| 2022-09-30 | -36.06x |
| 2022-06-30 | -25.26x |
| 2022-03-31 | -66.47x |
| 2021-12-31 | -238.73x |
| 2021-09-30 | -114.85x |
| 2021-06-30 | -34.61x |
| 2021-03-31 | -23.54x |
| 2020-12-31 | -42.13x |
